The Food and Drug Administration has received reports of radiation exposure during CT perfusion imaging procedures in other states in the wake of its investigation into patients who were exposed at Cedars-Sinai Medical Center in Los Angeles.
FDA fields more reports on excessive CT radiation
Patients in other states have reported hair loss or skin redness after the scans, according to an update by the FDA, which has been investigating incidents at the 909-bed hospital since October. The FDA also said it has identified 50 more patients elsewhere who were exposed to eight times the normal amount of radiation for the imaging procedure, and that the cases so far involved more than one manufacturer of CT scanners.
Based on its ongoing investigation, the FDA is recommending imaging facilities, radiologists and technicians take added steps to ensure patients' safety, including assessing whether patients who had CT perfusion scans received excess radiation; reviewing dosing protocols; checking the CT scanner display panel; and implementing quality-control procedures to ensure proper dosage.
What do you think? Post a comment on this article and share your opinion with other readers. Submit your letter to Modern Physician Online at [email protected]. Please be sure to include your hometown and state, along with your organization and title.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.